Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials.
BACKGROUND: Erythropoiesis-stimulating agents reduce anaemia in patients with cancer and could improve their quality of life, but these drugs might increase mortality. We therefore did a meta-analysis of randomised controlled trials in which these drugs plus red blood cell transfusions were compare...
Egile Nagusiak: | Bohlius, J, Schmidlin, K, Brillant, C, Schwarzer, G, Trelle, S, Seidenfeld, J, Zwahlen, M, Clarke, M, Weingart, O, Kluge, S, Piper, M, Rades, D, Steensma, D, Djulbegovic, B, Fey, M, Ray-Coquard, I, Machtay, M, Moebus, V, Thomas, G, Untch, M, Schumacher, M, Egger, M, Engert, A |
---|---|
Formatua: | Journal article |
Hizkuntza: | English |
Argitaratua: |
2009
|
Antzeko izenburuak
-
Cancer, meta-analysis and reporting biases: the case of erythropoiesis-stimulating agents
nork: Thomy Tonia, et al.
Argitaratua: (2013-05-01) -
Erythropoiesis: insights into pathophysiology and treatments in 2017
nork: Andrea Zivot, et al.
Argitaratua: (2018-03-01) -
Normal erythropoiesis and development of multiple myeloma
nork: Bouchnita A., et al.
Argitaratua: (2015-01-01) -
Single-agent purine analogues for the treatment of chronic lymphocytic leukaemia: a systematic review and meta-analysis.
nork: Steurer, M, et al.
Argitaratua: (2006) -
Purine antagonists for chronic lymphocytic leukemia: Results of a comprehensive meta-analysis
nork: Steurer, M, et al.
Argitaratua: (2005)